PATENT CLAIM ANALYSIS

Application Number: 15906268
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "233200"]

Abstract:
The present invention is directed to novel compounds of formula I and their use as therapeutic compounds.

Claim (Index 25):
The pharmaceutical composition according to  claim 19  comprising a compound selected from formulae Ii-1, Ii-2, Ii-3, Ii-4, Ii-5, Ii-6, Ii-7, Ii-8, Ij-1, Ij-2, Ij-3, Ij-4, Ij-5, Ij-6, Ij-7, Ij-8, Ik-1, Ik-2, Ik-3, Ik-4, Ik-5, Ik-6, Ik-7, Ik-8, Ii\u2032-1, Ii\u2032-2, Ii\u2032-3, Ii\u2032-4, Ii\u2032-5, Ii\u2032-6, Ii\u2032-7 and Ii\u2032-8 or a pharmaceutically acceptable salt or solvate thereof and at least one pharmaceutically acceptable carrier, diluent, excipient and/or adjuvant, wherein a depicts the bond linking R 1  to the piperazine moiety; and R 1 , X 1  and X 2  are as defined in claim  2 ; and Ar 4 , R 4 , R 4\u2032 , R 5 , R 5\u2032 , R 6 , R 7 , R 7\u2032 , M 1 , M 2  are as defined in claim  4 ; and Ar 5 , Ar 6 , Ar 7 , R 11 , R 12 , R 12\u2032 , R 13 , R 14 , R 14\u2032 , R 15 , R 16 , R 17 , R 34 , R 35 , X 3 , X 5 , X 6 , and are as defined in claim  6 .

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14349595', '14799208', '13627091', '15259922', '15205304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.822101599743176
- 35 USC 102 Novelty (BERT): 0.5904749590388056
- Combined Prediction Score: 0.798938935672739
- Mean Citation Score: 548.391766
- Max Citation Score: 607.86743
- Similarity Product: 391.7234678308296

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test